China
OptoMedic Technologies, Inc. is a high-tech company based in China, specializing in providing high-performance medical devices and services by leveraging cutting-edge optical and bio-optical technologies in the healthcare industry. Established in July 2013 by a team of experts in medical, biomedical, engineering, quality assurance, and regulatory affairs, OptoMedic is dedicated to technological innovations and offers a range of high-end medical devices. Their intraoperative endoscopic fluorescence navigation system has achieved global leadership and widespread adoption in various surgical departments.
The company has established subsidiaries and R&D labs in key cities across China, including Suzhou, Beijing, Changsha, and Wuhan. Additionally, OptoMedic is actively engaged in multidisciplinary collaborations with prestigious research and clinical institutions such as Tsinghua University, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, and Peking University School of Pharmaceutical Sciences, as well as top-tier teaching hospitals in China.
OptoMedic Technologies, Inc. recently secured a Venture Round investment on 31 December 2023 from Kunpeng Capital, signifying a crucial milestone in their growth trajectory. With their emphasis on innovative technology and a focus on offering multiple minimally invasive applications, OptoMedic is poised to make a significant impact in the healthcare industry and emerge as a key player in the global medical technology landscape.
